Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
Proteome Analysis

Below the proteome analysis is presented. The analysis methods are presented in the paper Propagating Differential Gene Expression in Protein Interaction Networks. If you are interested in the most reliable results choose the
value_type as 'ranked' since this provides a very robust analysis method.
intercation map as 'high confidence'
network_comparison type as 'Divided' since this leads to a natural grouping of similar proteins
filtered as 'true' since this will only use the microarray measurements that have a sufficiently large confidence level.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Filtered Value Type Gene Rank description green Interaction Map Network Comparison Type red network_comparison
Results: HTML CSV LaTeX
Showing element 101 to 150 of 77072 in total
Filtered: 0
Value Type: Measured

\def\wcA{0.125\textwidth}
\def\wcB{0.125\textwidth}
\def\wcC{0.125\textwidth}
\def\wcD{0.125\textwidth}
\def\wcE{0.125\textwidth}
\def\wcF{0.125\textwidth}
\def\wcG{0.125\textwidth}
\begin{longtable}{|c|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Interaction Map\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Network Comparison Type\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
26\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
block 23. [source:sptrembl;acc:q8nhw5]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5187.87\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
4561.13\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
626.74\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
fatty acid desaturase 1; linoleoyl-coa desaturase (delta-6-desaturase)-like 1; delta-5 desaturase; delta-5 fatty acid desaturase. [source:refseq;acc:nm\_013402]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
662\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
153\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
4.3268\vspace{3pt}}\\\cline{2-4}\cline{6-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
glucosamine-6-phosphate isomerase (ec 3.5.99.6) (glucosamine-6- phosphate deaminase) (gnpda) (glcn6p deaminase) (oscillin). [source:swissprot;acc:p46926]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
47\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
143\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
3.04255\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
ribosomal protein s6 kinase-like 1. [source:refseq;acc:nm\_031464]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2063\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
2965.5\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
902.5\vspace{3pt}}\\\cline{1-3}\cline{6-7}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
27\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
baculoviral iap repeat-containing protein 5 (apoptosis inhibitor survivin) (apoptosis inhibitor 4). [source:swissprot;acc:o15392]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
13463.1\vspace{3pt}}&&&\parbox{\wcF}{\vspace{3pt}\noindent
14357.1\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
894\vspace{3pt}}\\\cline{2-4}\cline{6-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
candidate tumor suppressor protein. [source:refseq;acc:nm\_020381]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2821.67\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&&\parbox{\wcF}{\vspace{3pt}\noindent
2232\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
589.67\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma antigen, family d, 4 isoform 1; mage1 protein; mage-e1 protein; maged4 protein. [source:refseq;acc:nm\_030801]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
35.5\vspace{3pt}}&&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
105.5\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
2.97183\vspace{3pt}}\\\cline{2-4}\cline{6-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
phenylethanolamine n-methyltransferase (ec 2.1.1.28) (pnmtase) (noradrenaline n-methyltransferase). [source:swissprot;acc:p11086]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
139\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
570\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcG}{\vspace{3pt}\noindent
4.10072\vspace{3pt}}}\\\cline{1-2}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
28\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
beta-carotene dioxygenase 2; putative b,b-carotene-9',10'-dioxygenase. [source:refseq;acc:nm\_031938]\vspace{3pt}}&&&&&\\\cline{2-4}\cline{6-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen 3 (mage-3 antigen) (antigen mz2-d). [source:swissprot;acc:p43357]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
35.5\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
105.5\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
2.97183\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
spectrin beta chain, brain 4 (spectrin, non-erythroid beta chain 4) (beta-v spectrin) (bspecv). [source:swissprot;acc:q9nrc6]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4543.75\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
5418.2\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
874.45\vspace{3pt}}\\\cline{2-4}\cline{6-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
supervillin isoform 1; membrane-associated f-actin binding protein p205; archvillin. [source:refseq;acc:nm\_003174]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2821.67\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&&\parbox{\wcF}{\vspace{3pt}\noindent
2232\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
589.67\vspace{3pt}}\\\cline{1-3}\cline{6-7}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
29\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cytochrome c oxidase polypeptide viic, mitochondrial precursor (ec 1.9.3.1). [source:swissprot;acc:p15954]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
21088.5\vspace{3pt}}&&&\parbox{\wcF}{\vspace{3pt}\noindent
20505.7\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
582.8\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen 11 (mage-11 antigen). [source:swissprot;acc:p43364]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
35.5\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
105.5\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
2.97183\vspace{3pt}}\\\cline{2-4}\cline{6-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
potassium voltage-gated channel, shal-related subfamily, member 2; voltage-sensitive potassium channel; voltage-gated potassium channel kv4.2. [source:refseq;acc:nm\_012281]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
434.911\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&&\parbox{\wcF}{\vspace{3pt}\noindent
111.278\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
3.90833\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
regulator of chromosome condensation (cell cycle regulatory protein). [source:swissprot;acc:p18754]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2399.76\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
3248.95\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
849.19\vspace{3pt}}\\\cline{1-3}\cline{6-7}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
30\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cleavage and polyadenylation specificity factor, 160 kda subunit (cpsf 160 kda subunit). [source:swissprot;acc:q10570]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4102.97\vspace{3pt}}&&&\parbox{\wcF}{\vspace{3pt}\noindent
3265.25\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
837.72\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
dystrophin. [source:swissprot;acc:p11532]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
111.739\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
427.217\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
3.82335\vspace{3pt}}\\\cline{2-4}\cline{6-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen 2 (mage-2 antigen). [source:swissprot;acc:p43356]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
35.5\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&&\parbox{\wcF}{\vspace{3pt}\noindent
105.5\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
2.97183\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
protein kinase, lysine deficient 3. [source:refseq;acc:nm\_020922]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
704.5\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
125\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
579.5\vspace{3pt}}\\\cline{1-3}\cline{6-7}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
31\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
adenomatous polyposis coli like. [source:refseq;acc:nm\_005883]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3114.19\vspace{3pt}}&&&\parbox{\wcF}{\vspace{3pt}\noindent
2544.19\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
570\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
dok-like protein. [source:refseq;acc:nm\_024872]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
35\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
3500000\vspace{3pt}}\\\cline{2-4}\cline{6-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
hepatocellular carcinoma-associated protein hca1. [source:refseq;acc:nm\_020932]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
35.5\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
105.5\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
2.97183\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
spectrin alpha chain, brain (spectrin, non-erythroid alpha chain) (alpha-ii spectrin) (fodrin alpha chain). [source:swissprot;acc:q13813]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2637\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1833\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
804\vspace{3pt}}\\\cline{1-3}\cline{5-7}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
32\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cell division protein kinase 8 (ec 2.7.1.-) (protein kinase k35). [source:swissprot;acc:p49336]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
184\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
598\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
3.25\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
dead-box protein abstrakt homolog. [source:swissprot;acc:q9ujv9]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3026.64\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2476.1\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
550.54\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen 6 (mage-6 antigen) (mage3b). [source:swissprot;acc:p43360]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
35.5\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
105.5\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
2.97183\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
mln 64 protein (star-related lipid transfer protein 3) (stard3) (start domain-containing protein 3) (cab1 protein). [source:swissprot;acc:q14849]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
58\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
859\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
801\vspace{3pt}}\\\cline{1-3}\cline{5-7}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
33\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
lim domain binding 1; carboxy terminal lim domain protein 2; lim domain-binding factor-1. [source:refseq;acc:nm\_003893]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
39.8063\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
12.6208\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
3.15402\vspace{3pt}}\\\cline{2-4}\cline{6-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen d1 (mage-d1 antigen) (neurotrophin receptor-interacting mage homolog) (pro2292). [source:swissprot;acc:q9y5v3]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
35.5\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
105.5\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
2.97183\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
protein cgi-147. [source:swissprot;acc:q9y3e5]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
9192.38\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
8396.12\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
796.26\vspace{3pt}}\\\cline{2-4}\cline{6-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
scribble. [source:refseq;acc:nm\_015356]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4245.16\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
3697.8\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
547.36\vspace{3pt}}\\\cline{1-4}\cline{6-7}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
34\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
acrc protein; putative nuclear protein. [source:refseq;acc:nm\_052957]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3340.03\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&&\parbox{\wcF}{\vspace{3pt}\noindent
4131.06\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
791.03\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
glucosamine-6-phosphate isomerase (ec 3.5.99.6) (glucosamine-6- phosphate deaminase) (gnpda) (glcn6p deaminase) (oscillin). [source:swissprot;acc:p46926]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
47\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
143\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
3.04255\vspace{3pt}}\\\cline{2-4}\cline{6-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen f1 (mage-f1 antigen). [source:swissprot;acc:q9hay2]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
35.5\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&&\parbox{\wcF}{\vspace{3pt}\noindent
105.5\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
2.97183\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
peptide chain release factor 1, mitochondrial precursor (mrf-1). [source:swissprot;acc:o75570]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1361.92\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
840.74\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
521.18\vspace{3pt}}\\\hline
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
35\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
adp,atp carrier protein, liver isoform t2 (adp/atp translocase 3) (adenine nucleotide translocator 3) (ant 3). [source:swissprot;acc:p12236]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1377\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
459.5\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
2.99674\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
fatty acid desaturase 1; linoleoyl-coa desaturase (delta-6-desaturase)-like 1; delta-5 desaturase; delta-5 fatty acid desaturase. [source:refseq;acc:nm\_013402]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
662\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
153\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
509\vspace{3pt}}\\\cline{2-4}\cline{6-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
filamin a (alpha-filamin) (filamin 1) (endothelial actin-binding protein) (abp-280) (nonmuscle filamin). [source:swissprot;acc:p21333]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
898\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
1603\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
705\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen 4 (mage-4 antigen) (mage-x2) (mage-41). [source:swissprot;acc:p43358]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
35.5\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
105.5\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
2.97183\vspace{3pt}}\\\cline{1-4}\cline{6-7}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
36\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
heparan sulfate 6-o-sulfotransferase 2. [source:refseq;acc:nm\_147174]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
56\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
157\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
2.80357\vspace{3pt}}\\\cline{2-4}\cline{6-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen 9 (mage-9 antigen). [source:swissprot;acc:p43362]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
35.5\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
105.5\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
2.97183\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
oligosaccharyl transferase stt3 subunit homolog (b5) (integral membrane protein 1) (tmc). [source:swissprot;acc:p46977]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
925.298\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
1586.07\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
660.772\vspace{3pt}}\\\cline{2-4}\cline{6-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
ribosomal protein s6 kinase-like 1. [source:refseq;acc:nm\_031464]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1279.64\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
1763.83\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
484.19\vspace{3pt}}\\\hline
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
37\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
1,4-alpha-glucan branching enzyme (ec 2.4.1.18) (glycogen branching enzyme) (brancher enzyme). [source:swissprot;acc:q04446]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
934.348\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
334.401\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
2.79409\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
glutamate dehydrogenase 2, mitochondrial precursor (ec 1.4.1.3) (gdh). [source:swissprot;acc:p49448]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5452.71\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5931.43\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
478.72\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen 8 (mage-8 antigen). [source:swissprot;acc:p43361]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
35.5\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
105.5\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
2.97183\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
wiskott-aldrich syndrome protein family member 3 (wasp-family protein member 3) (verprolin homology domain-containing protein 3). [source:swissprot;acc:q9upy6]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4550.64\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
5202.89\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
652.25\vspace{3pt}}\\\cline{1-3}\cline{6-7}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
38\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
clathrin heavy chain 2 (clh-22). [source:swissprot;acc:p53675]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6127.24\vspace{3pt}}&&&\parbox{\wcF}{\vspace{3pt}\noindent
5497.01\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
630.23\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen c1 (mage-c1 antigen) (cancer-testis antigen ct7). [source:swissprot;acc:o60732]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
35.5\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
105.5\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
2.97183\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/